Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4802-4804, Vol. 68, No. 8
School of Microbiology and Immunology,
University of New South Wales, Sydney, New South Wales 2052, Australia
Received 22 February 2000/Returned for modification 9 April
2000/Accepted 4 May 2000
Helicobacter pylori-induced gastritis is an essential
precursor lesion for the development of peptic ulcers or gastric
adenocarcinoma. We demonstrate that nonresponsiveness to H. pylori SS1 infection is dominantly inherited in mice.
F1 hybrid crosses between a nonresponder mouse and three
responder strains all possessed the nonresponder phenotype. Secretion
of interleukin-10 but not gamma interferon was associated with
nonresponsiveness to infection.
Half of the world's population is
infected with the stomach-dwelling bacterium Helicobacter
pylori (18). Why some individuals develop symptomatic
disease, such as peptic ulceration or gastric adenocarcinoma (4,
9), while most H. pylori-infected hosts present with
asymptomatic gastritis is not fully understood. The various disease
manifestations are clearly multifactorial, with bacterial and
environmental factors being important (7, 8, 15), but host
genetic factors also exert significant influence (2, 20).
We and others have shown previously that Helicobacter felis
infection of inbred mice with different genetic backgrounds induces a
dichotomy of inflammatory responses (12, 20, 21, 23). Most
mice respond to H. felis infection with corpal gastritis, but some strains such as BALB/c and CBA do not develop inflammation; we
term these mice nonresponders. We further dissected the basis of this
nonresponsiveness using F1 hybrid mice, crossing three responder strains with nonresponder CBA/Ca mice. Infection of these
mice with H. felis demonstrated that the nonresponder
phenotype was dominantly inherited, and we hypothesized that
"suppressive" mechanisms exist which can inhibit the normal
inflammatory response induced by H. felis infection
(23).
Here we report that dominant inheritance of nonresponsiveness to
H. pylori infection also occurs in mice. Additionally, we examined the cellular response which associates with the nonresponder phenotype, using both H. pylori (the human pathogen) and
H. felis, which induces greater inflammation in responder mice.
Mice of the parental strains CBA/Ca, C3H/He, C57BL/6, and SJL and the
F1 hybrid strains CBA × C57BL/6, CBA × C3H/He,
and SJL × CBA (maternal × paternal) were bred in the School
of Microbiology and Immunology Animal Facility, University of New South
Wales. Protocols involving animal experimentation were approved by the Animal Care and Ethics Committee at the University of New South Wales.
Eight females of each strain were infected with H. pylori SS1 as previously described (17), with four noninfected
controls. Six months postinfection, mice were sacrificed and gastritis
was assessed histologically on blinded sections stained with
hematoxylin and eosin (13). Each stomach was graded for
activity (neutrophils) and mononuclear inflammatory cells in the antrum
and body as follows: 1, mild multifocal; 2, mild widespread or moderate
multifocal; 3, mild widespread and moderate multifocal or severe
multifocal; 4, moderate widespread; 5, moderate widespread and severe
multifocal; 6, severe widespread. The total number of lymphoid
follicles and gland abscesses in each section was counted.
Examination revealed neutrophilic and mononuclear cell infiltration
into the gastric tissue of infected C3H/He, C57BL/6, and SJL mice
(Table 1). Infected mice of these strains
also presented with gland abscesses, and SJL mice developed significant
lymphoid aggregates. All these parameters were significantly increased from those of CBA/Ca and all F1 hybrid mice
(Kruskal-Wallis; P < 0.05), which had either extremely
mild or no gastritis (Table 1). There was no significant difference
between CBA/Ca mice and the F1 hybrids. Thus, the
inflammatory phenotype of all F1 strains was the same as
that of the nonresponder CBA/Ca parent and different from those of
their respective responder parents.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Dominant Nonresponsiveness to Helicobacter
pylori Infection Is Associated with Production of Interleukin
10 but Not Gamma Interferon
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Histopathological gradings of parental and F1
hybrid mice with or without H. pylori infection.a
A Th1 immune response is responsible for cell-mediated immunity, is
proinflammatory, and is marked by the production of cytokines including
gamma interferon (IFN-
) and interleukin-12 (IL-12). IL-12 is a key
cytokine in the induction of a Th1 response leading to the production
of IFN-
. IFN-
has been shown to be produced in the stomachs of
both humans and mice infected with H. pylori (3, 11,
22) and is almost certainly a key factor in driving Helicobacter-induced gastritis. IL-10 can inhibit the
production of IL-12 and thus downregulate the proinflammatory Th1-type
response (10).
Thus, the IFN-
and IL-10 cytokine response to
Helicobacter infection was assessed in CBA/Ca, C57BL/6, and
their (CBA × C57BL/6)F1 hybrid mice (Walter Eliza
Hall Institute, Melbourne, Australia). Ten females of each strain were
infected with H. felis or H. pylori or left
uninfected for 3 months. Histopathological examination, as described
above, confirmed that in contrast to the responder C57BL/6 mice, the
nonresponder CBA/Ca and (CBA × C57BL/6)F1 hybrid mice
developed no gastritis whether infected with H. felis or H. pylori (data not shown).
Spleen cell suspensions were depleted of red cells by hypotonic shock
in water, and remaining splenocytes were cultured at 106/ml
in complete medium (RPMI 1640 medium [Gibco BRL, Gaithersburg, Md.)
with 10% fetal calf serum, 2 mM glutamine, 50 IU of penicillin/ml, 50 µg of streptomycin [Trace Biosciences, Castle Hill, New South Wales,
Australia] per ml, and 2.5 µg of amphotericin B [Bristol-Myers Squibb, Princeton, N.J.] per ml) with or without H. pylori
or H. felis lysate at 5 µg/ml. After 2 days of incubation
at 37°C with 5% CO2, the supernatants were collected for
the assessment of cytokines by standard enzyme-linked immunosorbent
assay. Maxisorp immunoplates (Nunc, Roskilde, Denmark) were coated with
anticytokine antibodies (Pharmingen, San Diego, Calif.) in
bicarbonate buffer (pH 9.6). Wells were blocked with 1% (wt/vol)
bovine serum albumin in phosphate-buffered saline. Culture supernatants
or serial dilutions of recombinant IL-10 (Pharmingen) or IFN-
(Sigma, St. Louis, Mo.) in complete medium were added to wells in
duplicate. Biotinylated anticytokine antibodies (Pharmingen) in
phosphate-buffered saline-bovine serum albumin were added, followed by
streptavidin-alkaline phosphatase (Zymed, South San Francisco, Calif.).
Color was developed by the addition of Sigma 104 phosphatase substrate
tablets (Sigma) dissolved in diethanolamine buffer. Absorbance was read
at 405 nm. A standard curve was plotted for each recombinant cytokine,
from which cytokine levels in supernatants were determined.
Cytokine production was observed only following culture with Helicobacter antigens, and interestingly, the infectious status appeared to be irrelevant. There was virtually no difference in the cytokine patterns whether from uninfected or H. felis- or H. pylori-infected mice. This suggests that the host mounts an inherent response upon the first exposure to Helicobacter antigens, whether in the form of lysate or viable whole bacteria. This initial response apparently dictates the type of long-term immune response that develops.
Nonresponder CBA/Ca mice produced very low levels of IFN-
but large
amounts of IL-10 (Fig. 1). Responder
C57BL/6 mice produced high levels of IFN-
but little or no IL-10.
Nonresponder F1 hybrid CBA × C57BL/6 mice produced
high levels of IFN-
, significantly more than the CBA/Ca parent
(one-way analysis of variance; P < 0.001) but not
significantly more or less than the C57BL/6 mice. Inverse to this,
F1 mice produced high levels of IL-10 like the CBA/Ca
parent but significantly more than the C57BL/6 mice (P < 0.05). Thus, regarding cytokine production, the nonresponder F1 mice were true hybrids, secreting IL-10 like the CBA/Ca
nonresponders, but surprisingly also produced IFN-
levels
indistinguishable from those of their responder C57BL/6 parents.
IFN-
would classically be expected to produce inflammation and has
been shown to mask the detection of Th2 cytokines in
Helicobacter-immunized mice (19). This raises the
possibility that IL-10 can be a dominant factor in controlling
Helicobacter-induced gastritis. The production of IFN-
was apparently irrelevant with its proinflammatory effects clearly
overridden, possibly by the inhibitory activity of IL-10.
|
The same situation may exist in humans, with several studies showing
the production of both IL-10 and IFN-
in response to H. pylori (1, 14). Bodger et al. reported higher
production of IL-10 in H. pylori-infected individuals than
in noninfected persons and those with Helicobacter-negative
gastritis. IL-10 was associated with the severity of inflammation; the
authors proposed that the increased secretion of this cytokine may be part of the host's attempt to control the inflammation (6).
Evidence from knockout mice deficient in IL-10 also suggests a role for this cytokine in controlling the inflammatory response to infection with Helicobacter hepaticus (16) and H. felis (5). There may be unknown consequences of the complete lack of IL-10 for immune development in these mice; thus, an advantage of the F1 hybrid model is that the mice used are immunocompetent. The demonstration of an association of cytokine profile with inflammatory response supports the knockout mouse data and allows greater confidence in concluding that IL-10 is an important factor controlling Helicobacter-induced gastritis.
In summary, we have confirmed that host genetic mechanisms that
influence inflammation in H. felis-infected mice also
control responses to the human pathogen H. pylori. Using
these models, we have demonstrated that production of IL-10 but not of
IFN-
is associated with the nonresponsiveness of certain strains of mice to Helicobacter infection. Determining the basis of
unresponsiveness will allow us to better understand H. pylori pathogenesis and may provide vital information regarding
individuals at risk of developing the more severe complications of an
H. pylori infection.
| |
ACKNOWLEDGMENTS |
|---|
This work was partly funded by the National Health and Medical Research Council and CSL Ltd., Melbourne, Australia.
We thank Nathan Moss for help with statistical analyses.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: School of Microbiology and Immunology, University of New South Wales, Sydney, NSW 2052, Australia. Phone: 61-2-9385-2098. Fax: 61-2-9385-1591. E-mail: P.Sutton{at}unsw.edu.au.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aihara, M., K. Imagawa, Y. Funakoshi, Y. Ohmoto, and M. Kikuchi. 1998. Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig. Dis. Sci. 43:S160-S166. |
| 2. | Azuma, T., S. Ito, F. Sato, Y. Yamazaki, H. Miyaji, Y. Ito, H. Suto, M. Kuriyama, T. Kato, and Y. Kohli. 1998. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82:1013-1018[CrossRef][Medline]. |
| 3. | Bamford, K. B., X. J. Fan, S. E. Crowe, J. F. Leary, W. K. Gourley, G. K. Luthra, E. G. Brooks, D. Y. Graham, V. E. Reyes, and P. B. Ernst. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492[CrossRef][Medline]. |
| 4. | Bell, G. D., C. M. Bate, A. T. R. Axon, G. Tildesley, J. L. Martin, M. D. Taylor, and P. D. I. Richardson. 1996. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. Aliment. Pharmacol. Ther. 10:637-644[CrossRef][Medline]. |
| 5. |
Berg, D. J.,
N. A. Lynch,
R. G. Lynch, and D. M. Lauricella.
1998.
Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10( / ) mice.
Am. J. Pathol.
152:1377-1386[Abstract].
|
| 6. |
Bodger, K.,
J. I. Wyatt, and R. V. Heatley.
1997.
Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor- secretion.
Gut
40:739-744 |
| 7. |
Censini, S.,
C. Lange,
Z. Y. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653 |
| 8. | Cohen, A. J., and F. J. C. Roe. 1997. Evaluation of the aetiological role of dietary salt exposure in gastric and other cancers in humans. Food Chem. Toxicol. 35:271-293[CrossRef][Medline]. |
| 9. |
Correa, P., and M. Miller.
1995.
Helicobacter pylori and gastric atrophy cancer paradoxes.
J. Natl. Cancer Inst.
87:1731-1732 |
| 10. |
D'Andrea, A.,
M. Aste-Amezaga,
N. M. Valiante,
X. Ma,
M. Kubin, and G. Trinchiere.
1993.
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
J. Exp. Med.
178:1041-1048 |
| 11. | Delios, M. M., M. Manghetti, M. Decarli, F. Costa, C. T. Baldari, D. Burroni, J. L. Telford, S. Romagnani, and G. Delprete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967[Abstract]. |
| 12. | Dey, A., K. Yokota, K. Kosavashi, K. Oguma, Y. Hirai, and T. Akagi. 1998. Antibody and cytokine responses in Helicobacter pylori-infected various mouse strains. Acta Med. Okayama 52:41-48. |
| 13. | Eaton, K. A., M. J. Radin, and S. Krakowka. 1995. An animal model of gastric ulcer due to bacterial gastritis in mice. Vet. Pathol. 32:489-497[Abstract]. |
| 14. | Karttunen, R. A., T. J. Karttunen, M. M. Yousfi, H. Elzimaity, D. Y. Graham, and F. Elzaatari. 1997. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 32:22-27[Medline]. |
| 15. | Kato, I., S. Tominaga, and K. Matsumoto. 1992. A prospective study of stomach cancer among a rural Japanese population: a 6-year survey. Jpn. J. Cancer Res. 83:568-575[Medline]. |
| 16. |
Kullberg, M. C.,
J. M. Ward,
P. L. Gorelick,
P. Caspar,
S. Hieny,
A. Cheever,
D. Jankovic, and A. Sher.
1998.
Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.
Infect. Immun.
66:5157-5166 |
| 17. | Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397[CrossRef][Medline]. |
| 18. | Mitchell, H. M. 1997. The epidemiology of Helicobacter pylori. Bailliere's Clin. Infect. Dis. 4:257-281. |
| 19. | Mohammadi, M., S. Czinn, R. Redline, and J. Nedrud. 1996. Helicobacter-specific cell-medicated immune responses display a predominant TH1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:4729-4738[Abstract]. |
| 20. | Mohammadi, M., R. Redline, J. Nedrud, and S. Czinn. 1996. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect. Immun. 64:238-245[Abstract]. |
| 21. |
Sakagami, T.,
M. Dixon,
J. O'Rourke,
R. Howlett,
F. Alderuccio,
J. Vella,
T. Shimoyama, and A. Lee.
1996.
Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis.
Gut
39:639-648 |
| 22. |
Sawai, N.,
M. Kita,
T. Kodama,
T. Tanahashi,
Y. Yamaoka,
Y.-I. Tagawa,
Y. Iwakura, and J. Imanishi.
1999.
Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Infect. Immun.
67:279-285 |
| 23. |
Sutton, P.,
J. Wilson,
R. Genta,
D. Torrey,
A. Savinainen,
J. Pappo, and A. Lee.
1999.
A genetic basis for atrophy: dominant nonresponsiveness and helicobacter induced gastritis in F-1 hybrid mice.
Gut
45:335-340 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»